Gut Microbiota and Alcoholic Liver Disease

Area of Science:

• Gastroenterology and Hepatology
• Microbiology
• Immunology

Background:

• The gut-liver axis is crucial in liver disease, including Non-Alcoholic Liver Steatosis (NAFLD) and Alcohol Liver Disease (ALD).
• Altered Intestinal Permeability (IP) allows gut-derived toxins to reach the liver, contributing to liver damage.
• Alcohol ingestion significantly impacts gut microbiota composition and function.

Purpose of the Study:

• To review the definition and physiopathology of ALD.
• To explore the role of gut microbiota and IP in ALD.
• To discuss emerging strategies for ALD treatment targeting the gut microbiota.

Main Methods:

• Literature review of existing studies on ALD, gut microbiota, and IP.
• Analysis of evidence from clinical and non-clinical studies on gut microbiota modulation for ALD.
• Synthesis of current understanding of the gut-liver axis in ALD.

Main Results:

• Alcohol significantly alters gut microbiota composition and increases intestinal permeability.
• These gut alterations are central to ALD development and progression.
• Preliminary studies suggest that modulating gut microbiota can be a viable therapeutic strategy for ALD.

Conclusions:

• The gut is a key player in ALD, with microbiota and IP being critical factors.
• Targeting the gut microbiota offers a promising avenue for novel ALD treatments.
• Further research is needed to validate these therapeutic approaches in clinical settings.